New Drug Combination Redefines First-Line Treatment for Advanced Urothelial Cancer
July 1, 2025
Recent developments have introduced promising therapies, notably the combination of enfortumab vedotin with pembrolizumab, which is now recommended as the first-line therapy following the EV-302 trial results.”BUFFALO, NY - July... read more